BASSO CAPITAL MANAGEMENT, L.P. - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K204. A total of 22 filers reported holding PHOENIX BIOTECH ACQUISITION in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BASSO CAPITAL MANAGEMENT, L.P. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q2 2022$755,000
+0.1%
74,9610.0%0.08%
+9.7%
Q1 2022$754,000
-0.3%
74,9610.0%0.07%
-13.3%
Q4 2021$756,00074,9610.08%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q3 2022
NameSharesValueWeighting ↓
DIFESA CAPITAL MANAGEMENT, LP 125,000$1,265,0000.64%
Wealthspring Capital LLC 177,300$1,789,0000.35%
Castle Creek Arbitrage, LLC 400,000$4,036,0000.22%
Shaolin Capital Management LLC 750,000$7,568,0000.21%
Schechter Investment Advisors, LLC 149,660$1,510,0000.15%
Yakira Capital Management, Inc. 100,000$1,009,0000.15%
Silver Rock Financial LP 46,243$467,0000.10%
Westchester Capital Management, LLC 150,000$1,518,0000.04%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 16,641$168,0000.02%
Walleye Capital LLC 49,694$501,0000.01%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders